書誌情報

Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma

Ken Ohta(a), Mitsuru Adachi(b), Yuji Tohda(c), Tadashi Kamei(d), Motokazu Kato(e), J. Mark Fitzgerald(f), Masayuki Takanuma(g), Tadahiro Kakuno(g), Nobuyuki Imai(g), Yanping Wu(h), Magnus Aurivillius(i), Mitchell Goldman(h)
(a)National Hospital Organization, Tokyo National Hospital, (b)International University of Health and Welfare Sauna Hospital, (c)Kindai University Faculty of Medicine, (d)Kamei Respiratory Clinic, (e)Kishiwada City Hospital, (f)The Lung Centre, Vancouver General Hospital, UBC Institute for Heart and Lung Health, (g)Kyowa Hakko Kirin Co.,Ltd., (h)AstraZeneca, Gaithersburg, (i)AstraZeneca, Molndal
Allergology International 67(2): 266-272, 2018.

個人会員・法人会員の方(IDが5または10で始まる方)

  • アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。

ライブラリー会員の方(IDが11または12で始まる方)